These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3987029)

  • 1. Spectrin extractability from erythrocytes in Duchenne muscular dystrophy patients and carriers and in other myopathies.
    Gargioni G; Chiaffoni G; Bonadonna G; Corradini P; Lechi C; de Grandis D; Zatti M
    Clin Chim Acta; 1985 Feb; 145(3):259-65. PubMed ID: 3987029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrin extractability from erythrocyte in Duchenne muscular dystrophies and the effect of proteases on erythrocyte ghosts.
    Tsuchiya Y; Sugita H; Ishiura S; Imahori K
    Clin Chim Acta; 1981 Feb; 109(3):285-93. PubMed ID: 6452973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased phosphorylated components of erythrocyte membrane spectrin band II with reference to Duchenne muscular dystrophy.
    Roses AD; Herbstreith M; Metcalf B; Appel SH
    J Neurol Sci; 1976 Nov; 30(1):167-78. PubMed ID: 10352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of membrane phosphorylation in erythrocyte membranes from patients with Duchenne muscular dystrophy.
    Vickers JD; McComas AJ; Rathbone MP
    Can J Neurol Sci; 1978 Nov; 5(4):437-42. PubMed ID: 743652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte spectrofluorometric abnormalities in Duchenne patients and carriers. A new approach to carrier detection.
    Scarlato G; Meola G; Silani V; Manfredi L; Bottiroli G; Zanella A
    Acta Neurol Scand; 1979 May; 59(5):262-9. PubMed ID: 474067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocyte spectrin peak II phosphorylation in Duchenne muscular dystrophy.
    Roses AD; Appel SH
    J Neurol Sci; 1976 Oct; 29(2-4):185-93. PubMed ID: 978207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of abnormally [32P]-phosphorylated cyanogen bromide cleavage product of erythrocyte membrane spectrin in Duchenne muscular dystrophy.
    Roses AD; Shile PE; Herbstreith MH; Balakrishnan CV
    Neurology; 1981 Aug; 31(8):1026-30. PubMed ID: 7196515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection.
    Percy ME; Chang LS; Murphy EG; Oss I; Verellen-Dumoulin C; Thompson MW
    Muscle Nerve; 1979; 2(5):329-39. PubMed ID: 492209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical relationships between muscle and erythrocyte membrane. Interpretations with respect to Duchenne muscular dystrophy.
    Roses AD; Herbstreith MH; Metcalf BS; Hartwig GB
    Electroencephalogr Clin Neurophysiol Suppl; 1978; (34):463-8. PubMed ID: 285848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenylate cyclase and ATPase activities in red cell membranes of patients and genetic carriers of Duchenne muscular dystrophy.
    Wacholtz MC; Raible DG; Jackowski S; Rodan SB; Rodan GA; Sha'afi RI
    Clin Chim Acta; 1979 Sep; 96(3):255-9. PubMed ID: 158446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminished spectrin extraction from ATP-depleted human erythrocytes. Evidence relating spectrin to changes in erythrocyte shape and deformability.
    Lux SE; John KM; Ukena TE
    J Clin Invest; 1978 Mar; 61(3):815-27. PubMed ID: 25286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical compositional studies of erythrocyte membranes in Duchenne muscular dystrophy.
    Godin DV; Bridges MA; MacLeod PJ
    Res Commun Chem Pathol Pharmacol; 1978 May; 20(2):331-49. PubMed ID: 674819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echinogenic action of L-alpha-lysophosphatidylcholine in Duchenne muscular dystrophy: a study on carrier detection.
    Tangorra A; Curatola G; Milani-Comparetti M; Ferretti G
    Am J Med Genet; 1989 Apr; 32(4):540-4. PubMed ID: 2774000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red blood cell and fibroblast membranes in Duchenne and myotonic muscular dystrophy.
    Roses AD; Hartwig GB; Mabry M; Nagano Y; Miller SE
    Muscle Nerve; 1980; 3(1):36-54. PubMed ID: 6246418
    [No Abstract]   [Full Text] [Related]  

  • 15. Myotonic dystrophy: fragility of band 3 membrane protein upon resealing of erythrocyte ghosts and the normality of ATPase activity, sialic acid content, and spectrin extractability of ghosts.
    Tsuchiya Y; Sugita H; Kuroiwa Y
    Biochem Med; 1983 Dec; 30(3):271-9. PubMed ID: 6228227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased [32P]-phosphorylation of tryptic peptides of erythrocyte spectrin in Duchenne muscular dystrophy.
    Mabry ME; Roses AD
    Muscle Nerve; 1981; 4(6):489-93. PubMed ID: 7311988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study of sialic acid of erythrocyte membranes in Duchenne muscular dystrophy].
    Shen DG
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Dec; 21(6):349-51, 385. PubMed ID: 3248452
    [No Abstract]   [Full Text] [Related]  

  • 18. Membrane fluidity of nonmuscle cells in Duchenne muscular dystrophy: effect on lymphocyte membranes of incubation in patient and control sera.
    Hübner C; Kohlschütter A; Gärtner J
    Pediatr Res; 1987 Oct; 22(4):488-92. PubMed ID: 3684376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte-ghost Ca2+-stimulated Mg2+-dependent adenosine triphosphatase in Duchenne muscular dystrophy.
    Dunn MJ; Burghes AH; Dubowitz V
    Biochem J; 1982 Mar; 201(3):445-53. PubMed ID: 6124239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of water permeability and proteins of erythrocyte membranes in patients with Duchenne muscular dystrophy.
    Benga G; Popescu O; Pop VI; Ionescu I; Muresan A; Borza V; Hodârnău A; Popescu M; Serbu AM; Benga I
    Muscle Nerve; 1989 Apr; 12(4):294-301. PubMed ID: 2770782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.